Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
about
Interleukin-1 receptor antagonist for treating periodontitisInterleukin-1 receptor antagonist for treating periodontitisMuscle IL1β Drives Ischemic Myalgia via ASIC3-Mediated Sensory Neuron SensitizationElevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity.Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.Castleman's disease: from basic mechanisms to molecular therapeuticsStimulation of Proliferation and Migration of Mouse Macrophages by Type B CpG-ODNs Is F-Spondin and IL-1Ra Dependent.Therapeutic potential of targeting IL-1 and IL-18 in inflammation.The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells.CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis.Interleukin-1β and mitochondria damage, and the development of diabetic retinopathy.Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivoChlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cellsNeutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.Targeting interleukins to treat severe asthma.Methyl-1-hydroxy-2-naphthoate, a novel naphthol derivative, inhibits lipopolysaccharide-induced inflammatory response in macrophages via suppression of NF-κB, JNK and p38 MAPK pathways.Antagonists of IL-1R: a patent evaluation (WO2012122985).Role of the inflammasome in chronic obstructive pulmonary disease (COPD).Interleukin 1β inhibition contributes to the antinociceptive effects of voluntary exercise on ischemia/reperfusion-induced hypersensitivity.Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
P2860
Q24199001-590F7858-8E28-44E0-BF1E-CA63D5792F19Q24240691-1DEBBF7F-7EB6-4717-B55C-4F1FB2BFD021Q28828475-86EB0F6A-F9CB-49C7-B71B-0275B7580584Q34168638-09F7187E-6F6D-40EE-B33B-6E390E4A4EFEQ34336131-F1B6EB8A-6E37-483F-A431-D6144A669726Q34484529-FF6F94FB-BD83-4ACD-9D08-B1FCB02EA8DDQ35584575-E50EDCE0-EB87-49E7-A66C-4C543AEB213CQ35652625-7D8A2EF3-AC08-4C3F-AE9A-0A13ECEC473CQ35790840-F34E1A35-39C7-4A50-8178-B8C17E22B3D6Q35884530-67BDD8A1-2DEB-4218-9175-189E1725DBB7Q35919881-FC3383F5-0A57-4916-BFD9-356E43832867Q35928454-C214210F-8DCD-4150-A125-73B37160D931Q36053108-2FDC7D29-179B-4353-9EEA-9F2C2AA942BFQ36990651-A5782C87-19CD-4114-9BC3-04C4D0D06592Q37357640-44F6CF1C-9EC5-494C-9979-47AF2554604CQ38042721-12A191B6-77D1-409C-A876-190C00015849Q39525760-BF660B00-1F2C-4107-A8E7-7BC902953CE7Q44778262-8E9FD2B8-A12E-4D2F-8E54-97FE3608E13AQ47159702-3607354E-C767-43A1-841C-F91F056E15B9Q47233876-911AE929-2535-433C-810D-0DF7C9C3BED7Q49981026-191BCC0D-7BF4-4198-B84B-9394A7CA373C
P2860
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
@ast
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
@en
type
label
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
@ast
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
@en
prefLabel
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
@ast
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
@en
P2860
P356
P1476
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
@en
P2093
Hallegua DS
Weisman MH
P2860
P304
P356
10.1136/ARD.61.11.960
P407
P577
2002-11-01T00:00:00Z